Going on a very strict diet with very few calories can hurt your bones more than a moderate diet—even if you’re eating enough protein and calcium.
Scientific Claim
Very-low-calorie diets (VLCDs) (<800 kcal/day) during weight loss cause disproportionately greater bone mineral density loss compared to moderate energy restriction, even when protein and micronutrient targets are met.
Original Statement
“A 12-month RCT involving 101 postmenopausal women... VLCD using complete meal replacements and providing 1 g/kg/day of protein resulted in nearly double the weight loss (17.3 vs. 8.8%)... VLCD group experienced disproportionately greater losses in BMD, with a 2.1-fold greater reduction in total hip BMD (0.032 vs 0.015 g/cm²).”
Evidence Quality Assessment
Claim Status
overstated
Study Design Support
Design cannot support claim
Appropriate Language Strength
probability
Can suggest probability/likelihood
Assessment Explanation
The claim is based on a single RCT cited in a narrative review; causation cannot be generalized without more evidence, and the verb 'cause' overstates the review’s role.
More Accurate Statement
“Very-low-calorie diets (<800 kcal/day) during weight loss are likely to cause disproportionately greater bone mineral density loss compared to moderate energy restriction, even when protein and micronutrient targets are met.”
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aIn EvidenceMagnitude of BMD loss associated with VLCD vs. moderate ER across diverse populations.
Magnitude of BMD loss associated with VLCD vs. moderate ER across diverse populations.
What This Would Prove
Magnitude of BMD loss associated with VLCD vs. moderate ER across diverse populations.
Ideal Study Design
A meta-analysis of RCTs (n≥10) comparing VLCD (<800 kcal/day) vs. moderate ER (1200–1500 kcal/day) in adults with obesity (BMI ≥30), with standardized BMD measurements (DXA) at hip, spine, and forearm at 6 and 12 months, controlling for protein intake, age, sex, and menopausal status.
Limitation: Cannot determine if bone loss is reversible after diet cessation.
Randomized Controlled TrialLevel 1bIn EvidenceCausal effect of VLCD vs. moderate ER on BMD in postmenopausal women.
Causal effect of VLCD vs. moderate ER on BMD in postmenopausal women.
What This Would Prove
Causal effect of VLCD vs. moderate ER on BMD in postmenopausal women.
Ideal Study Design
A double-blind RCT of 100 postmenopausal women with obesity (BMI 30–40) randomized to VLCD (750 kcal/day, 1.2 g/kg protein, 1200 mg calcium, 800 IU vitamin D) vs. moderate ER (1500 kcal/day, same nutrients) for 12 months, with primary outcome: change in total hip BMD via DXA.
Limitation: Ethical constraints limit long-term VLCD use beyond 12 weeks in most populations.
Prospective Cohort StudyLevel 2bIn EvidenceLong-term fracture risk associated with prior VLCD use in obese adults.
Long-term fracture risk associated with prior VLCD use in obese adults.
What This Would Prove
Long-term fracture risk associated with prior VLCD use in obese adults.
Ideal Study Design
A 10-year prospective cohort of 2000 adults who underwent VLCD for weight loss (vs. matched controls) with annual BMD scans and incident fracture reporting, adjusting for age, activity, and medication use.
Limitation: Confounding by indication (e.g., VLCD users may have more severe obesity or comorbidities).
Evidence from Studies
No evidence studies found yet.